Study: NCT03430661

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: Tablet for oral administration (300 or 600 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: Tablet for oral administration (300 or 600 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: Tablet for oral administration (300 or 600 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Tablet for oral administration (60 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Tablet for oral administration (60 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Tablet for oral administration (60 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution